APOE ε4 influences medial temporalatrophy and tau deposition in atypical Alzheimer's disease

被引:15
作者
Singh, Neha Atulkumar [1 ]
Tosakulwong, Nirubol [2 ]
Graff-Radford, Jonathan [1 ]
Machulda, Mary M. [3 ]
Nha Trang Thu Pham [4 ]
Sintini, Irene [4 ]
Weigand, Stephen D. [2 ]
Schwarz, Christopher G. [4 ]
Senjem, Matthew L. [4 ]
Carrasquillo, Minerva M. [5 ]
Ertekin-Taner, Nilufer [5 ]
Jack, Clifford R., Jr. [4 ]
Lowe, Val J. [4 ]
Josephs, Keith A. [1 ]
Whitwell, Jennifer L. [4 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Radiol, 200 1st St SW, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Neurosci, Jacksonville, FL USA
基金
美国国家卫生研究院;
关键词
apolipoprotein epsilon 4; atypical Alzheimer's disease; logopenic progressive aphasia; posterior cortical atrophy; magnetic resonance imaging; tau positron emission tomography; POSTERIOR CORTICAL ATROPHY; CLINICAL PHENOTYPE; VARIANTS; ONSET; ASSOCIATION; AGE;
D O I
10.1002/alz.12711
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Apolipoprotein E (APOE) epsilon 4 is an important genetic risk factor for typical Alzheimer's disease (AD), influencing brain volume and tau burden. Little is known about its influence in atypical presentations of AD. Methods: An atypical AD cohort of 140 patients diagnosed with either posterior cortical atrophy or logopenic progressive aphasia underwent magnetic resonance imaging and positron emission tomography. Linear mixed effects models were fit to assess the influence of APOE epsilon 4 on cross-sectional and longitudinal regional metrics. Results: At baseline, APOE epsilon 4 carriers had smaller hippocampal and amygdala volumes and greater tau standardized uptake volume ratio in the hippocampus and entorhinal cortex compared to non-carriers while longitudinally, APOE epsilon 4 non-carriers showed faster rates of atrophy and tau accumulation in the entorhinal cortex, with faster tau accumulation in the hippocampus. Discussion: APOE epsilon 4 influences patterns of neurodegeneration and tau deposition and was associated with more medial temporal involvement, although there is evidence that non-carriers may be catching up over time.
引用
收藏
页码:784 / 796
页数:13
相关论文
共 50 条
[41]   Editorial: New insights into atypical Alzheimer's disease: from clinical phenotype to biomarkers [J].
Singh, Neha Atulkumar ;
Sintini, Irene .
FRONTIERS IN NEUROSCIENCE, 2024, 18
[42]   Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease [J].
Coburn, Ryan P. ;
Graff-Radford, Jonathan ;
Machulda, Mary M. ;
Schwarz, Christopher G. ;
Lowe, Val J. ;
Jones, David T. ;
Jack Jr, Clifford R. ;
Josephs, Keith A. ;
Whitwell, Jennifer L. ;
Botha, Hugo .
CORTEX, 2024, 180 :18-34
[43]   APOE ε4 and cognitive reserve effects on the functional network in the Alzheimer's disease spectrum [J].
Li, Ting ;
Wang, Bin ;
Gao, Yuan ;
Wang, Xin ;
Yan, Ting ;
Xiang, Jie ;
Niu, Yan ;
Liu, Tiantian ;
Chen, Duanduan ;
Fang, Boyan ;
Xie, Yunyan ;
Funahashi, Shintaro ;
Yan, Tianyi .
BRAIN IMAGING AND BEHAVIOR, 2021, 15 (02) :758-771
[44]   The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease [J].
Jia, Longfei ;
Xu, Hui ;
Chen, Shuoqi ;
Wang, Xiu ;
Yang, Jianwei ;
Gong, Min ;
Wei, Cuibai ;
Tang, Yi ;
Qu, Qiumin ;
Chu, Lan ;
Shen, Lu ;
Zhou, Chunkui ;
Wang, Qi ;
Zhao, Tan ;
Zhou, Aihong ;
Li, Ying ;
Li, Fangyu ;
Li, Yan ;
Jin, Hongmei ;
Qin, Qi ;
Jiao, Haishan ;
Zhang, Heng ;
Lyu, Diyang ;
Shi, Yuqing ;
Song, Yang ;
Jia, Jianping .
ALZHEIMERS & DEMENTIA, 2020, 16 (12) :1613-1623
[45]   Atypical clinical variants of Alzheimer's disease: are they really atypical? [J].
Whitwell, Jennifer L. .
FRONTIERS IN NEUROSCIENCE, 2024, 18
[46]   Association of APOE ε4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function [J].
Salami, Alireza ;
Adolfsson, Rolf ;
Andersson, Micael ;
Blennow, Kaj ;
Lundquist, Anders ;
Adolfsson, Annelie Nordin ;
Scholl, Michael ;
Zetterberg, Henrik ;
Nyberg, Lars .
JOURNAL OF ALZHEIMERS DISEASE, 2022, 85 (03) :1309-1320
[47]   Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical models [J].
Jablonski, Angela Marie ;
Warren, Lee ;
Usenovic, Marija ;
Zhou, Heather ;
Sugam, Jonathan ;
Parmentier-Batteur, Sophie ;
Voleti, Bhavya .
SCIENTIFIC REPORTS, 2021, 11 (01)
[48]   Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease [J].
Vance, Jeffery M. ;
Farrer, Lindsay A. ;
Huang, Yadong ;
Cruchaga, Carlos ;
Hyman, Bradley T. ;
Pericak-Vance, Margaret A. ;
Goate, Alison M. ;
Greicius, Michael D. ;
Griswold, Anthony J. ;
Haines, Jonathan L. ;
Julia, T. C. W. ;
Schellenberg, Gerard D. ;
Tsai, Li-Huei ;
Herz, Joachim ;
Holtzman, David M. .
ANNALS OF NEUROLOGY, 2024, 95 (04) :625-634
[49]   APOE4, Alzheimer's and periodontal disease: A scoping review [J].
Arevalo-Caro, Catalina ;
Retana, Marianela Arce ;
Amaya, Sergio Losada ;
Arboleda, Humberto ;
Gallart-Palau, Xavier ;
Serra, Aida .
AGEING RESEARCH REVIEWS, 2025, 105
[50]   The prevalence of apoE-ε4 in Alzheimer's disease is age dependent [J].
Frisoni, GB ;
Manfredi, M ;
Geroldi, C ;
Binetti, G ;
Zanetti, O ;
Bianchetti, A ;
Trabucchi, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (01) :103-106